1st Quarter - Report

PKD FOUNDATION for PKD FOUNDATION

Firm
Client
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Modernizing Our Drug and Diagnostic Evaluation and Regulatory Network (MODDERN) Cures Solution - No bill number yet; Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - No bill number yet; Discussed support for PKD Awareness Week

LobbyistCovered position, as disclosed
KIMBERLY CANTOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

FY 2011 National Institutes of Health (NIH) appropriations; FY 2012 NIH appropriations and report language to the FY 2012 Labor-Health and Human Services-Education Appropriations Act highlights polycystic kidney disease (PKD); Seeking support for including PKD in the FY 2012 Department of Defense Appropriations Act Peer-Reviewed Medical Research Program

LobbyistCovered position, as disclosed
KIMBERLY CANTOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.